Zio ECG Utilization Software (ZEUS) System vs EchoGo Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by iRhythm Technologies
VS
by Ultromics

AI Verdict

The Zio ECG Utilization Software (ZEUS) System focuses on the diagnosis and management of cardiac arrhythmias by analyzing continuous ECG data from wearable monitors. Conversely, EchoGo Pro specializes in automating stress echocardiography analysis to improve the diagnosis of coronary artery disease. While both are AI-powered cardiology tools, they address different cardiac conditions and utilize distinct diagnostic modalities, making them suitable for different clinical use cases.

Choose Zio ECG Utilization Software (ZEUS) System if…

Choose the Zio ECG Utilization Software (ZEUS) System if your primary need is continuous, long-term monitoring of a patient's ECG to detect and classify cardiac arrhythmias over an extended period. This system is ideal for identifying intermittent or elusive arrhythmias that might not be captured during a short office visit, providing comprehensive data for diagnosis and ongoing management.

View Zio ECG Utilization Software (ZEUS) System →

Choose EchoGo Pro if…

Choose EchoGo Pro if you require rapid, AI-powered analysis of stress echocardiograms to accurately diagnose coronary artery disease. This solution is best suited for cardiology practices seeking to streamline their echo interpretation workflow, improve diagnostic consistency, and obtain near-instant, comprehensive reports for timely patient management.

View EchoGo Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Zio ECG Utilization Software (ZEUS) System EchoGo Pro
Pricing Unknown Contact vendor for pricing
Deployment Cloud-based. Cloud-based
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoGo Pro

Tool B emphasizes a SaaS model requiring no software installation or extensive training, and its vendor-neutral compatibility with any PACS, suggesting a lower barrier to entry and easier integration into existing clinical imaging workflows. While Tool A offers a mobile application, Tool B's focus on seamless integration into diverse enterprise environments provides a stronger usability advantage for broad adoption.

Clinical Value

Tie

Both tools are FDA-cleared and leverage AI to enhance diagnostic accuracy in cardiology, but they address different clinical needs. Tool A focuses on continuous ECG monitoring for cardiac arrhythmias, while Tool B automates stress echocardiography analysis for coronary artery disease. Without comparative clinical outcome data across their distinct applications, it is not possible to definitively state one offers superior clinical value.

Pricing & Value

EchoGo Pro

Both tools require direct vendor contact for pricing, but Tool B explicitly mentions the availability of reimbursement codes for related EchoGo products. This transparency regarding potential reimbursement pathways provides a clearer understanding of the financial value proposition for healthcare providers, which is a significant advantage.

Enterprise Readiness

EchoGo Pro

Both tools are cloud-based, HIPAA compliant, FDA-cleared, and offer HL7 integration. However, Tool B's explicit mention of being a 'vendor-neutral system, compatible with any PACS' and supporting DICOM integration demonstrates a higher degree of interoperability and readiness for seamless integration into diverse and complex hospital imaging infrastructures.

Innovation

Zio ECG Utilization Software (ZEUS) System

While both tools are innovative in their respective domains, Tool A's integration of AI with long-term continuous data from wearable biosensors for arrhythmia detection represents a more transformative approach to cardiac monitoring. This method moves beyond episodic diagnostics by enabling extended, proactive data collection and analysis, offering a potentially more disruptive innovation in the field.

Support & Docs

Zio ECG Utilization Software (ZEUS) System

Tool A (iRhythm) offers a more comprehensive and explicitly detailed support ecosystem, including 24/7 customer care for patients, a dedicated provider support section, and patient-facing applications like MyZio, in addition to extensive Instructions for Use. While Tool B provides user manuals, the breadth of its support services is not as clearly articulated in the available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Zio ECG Utilization Software (ZEUS) System EchoGo Pro
Name Zio ECG Utilization Software (ZEUS) System EchoGo Pro
Company iRhythm Technologies Ultromics
Description AI-powered, cloud-based platform that analyzes continuous ECG data from wearable Zio monitors to aid physicians in the diagnosis and management of cardiac arrhythmias. FDA-cleared, AI-powered cloud solution that automates stress echocardiography analysis to improve the diagnosis of coronary artery disease, providing near-instant, accurate reports.
Primary Focus Diagnosis and management of cardiac arrhythmias through continuous ECG data analysis. Automated stress echocardiography analysis for diagnosis of coronary artery disease.
Key Feature 1 AI algorithm for arrhythmia detection and classification AI-powered automated echocardiogram analysis
Key Feature 2 Continuous ECG data analysis (up to 14 days) Cloud-based service for accessibility and scalability

Videos

Demos, reviews, and walkthroughs featuring Zio ECG Utilization Software (ZEUS) System and EchoGo Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Zio ECG Utilization Software (ZEUS) System by iRhythm Technologies is designed to aid physicians in the diagnosis and management of cardiac arrhythmias by analyzing continuous ECG data. EchoGo Pro by Ultromics automates stress echocardiography analysis to improve the diagnosis of coronary artery disease (CAD).
The Zio ECG Utilization Software (ZEUS) System analyzes continuous ECG data collected from wearable Zio monitors. EchoGo Pro analyzes echocardiogram data and is a vendor-neutral system, compatible with any PACS.
The Zio ECG Utilization Software (ZEUS) System offers HL7-based EHR integration. EchoGo Pro provides seamless integration with existing clinical workflows through DICOM and HL7, and is vendor-neutral with PACS.
The Zio ECG Utilization Software (ZEUS) System supports Cardiology, Family Medicine, and Internal Medicine. EchoGo Pro is specifically designed to support Cardiology.
The Zio ECG Utilization Software (ZEUS) System provides comprehensive end-of-wear reports for physician review and access via the ZioSuite web portal and mobile application. EchoGo Pro delivers near-instant, comprehensive reports.

Backers

Who funded each tool's parent company.

Zio ECG Utilization Software (ZEUS) System

AI Tool Finder
AI-powered search. Results may not be comprehensive.